Financial News
Biotech and Delisting Risk From China’s Perspective with WisdomTree
May 19, 2022 at 18:30 PM EDT
Liqian Ren, Ph.D., and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D., co-founder and CEO of Adagene, regarding developments in the pharmaceutical industry and business practices abroad in the most recent China of Tomorrow podcast from WisdomTree. Adagene is a biotech...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
